Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment

1. Reinoso-Segura, M.
2. Caballero-Velázquez, T.
3. Herrera, P.
4. Patriarca, F.
5. Fanin, R.
6. Bruno, B.
7. Einsele, H.
8. Nahi, H.
9. Granell, M.
10. López-Corral, L.
11. Reguera, J.L.
12. García-Cadenas, I.
13. Gahrton, G.
14. Pérez-Simón, J.A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.JTCT.2022.01.026 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus